[Kidney transplantation in patients positive for hepatitis C virus].
Campistol
J M
JM
Unidad de Trasplante Renal, Hospital Clínic, IDIBAPS (Institut d'Investigació Biomedique Agusti Pi i Sunyer), Universidad de Barcelona, Barcelona, Hospital 12 de Octubre, Madrid.
Esforzado
N
N
Morales
J M
JM
Barrera
J M
JM
D000465:Algorithms; D000998:Antiviral Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000635:transmission; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000209:etiology; D006085:Graft Survival; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery / Q000635:transmission; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects / Q000706:statistics & numerical data; D008103:Liver Cirrhosis / Q000209:etiology; D016031:Liver Transplantation; D011183:Postoperative Complications / Q000209:etiology; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects; D012189:Retrospective Studies; D012254:Ribavirin / Q000627:therapeutic use; D013030:Spain / Q000453:epidemiology; D016019:Survival Analysis; D014019:Tissue Donors; D016896:Treatment Outcome; D014850:Waiting Lists
D000998:Antiviral Agents; D012367:RNA, Viral; D012254:Ribavirin; D007372:Interferons